These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 33766889)

  • 1. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 replicon for high-throughput antiviral screening.
    Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
    Nguyen HT; Falzarano D; Gerdts V; Liu Q
    J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
    Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
    Zhang Y; Song W; Chen S; Yuan Z; Yi Z
    Antiviral Res; 2021 Jan; 185():104974. PubMed ID: 33217430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
    Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    Chen Z; Cui Q; Ran Y; Achi JG; Chen Z; Rong L; Du R
    J Virol; 2024 Jul; 98(7):e0050424. PubMed ID: 38899934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo.
    Li Y; Tan X; Deng J; Liu X; Liu Q; Zhang Z; Huang X; Shen C; Xu K; Zhou L; Chen Y
    Virol Sin; 2024 Jun; 39(3):447-458. PubMed ID: 38548102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
    Tanaka T; Saito A; Suzuki T; Miyamoto Y; Takayama K; Okamoto T; Moriishi K
    Antiviral Res; 2022 Mar; 199():105268. PubMed ID: 35271914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
    Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
    J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
    Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
    Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
    Kotaki T; Xie X; Shi PY; Kameoka M
    Sci Rep; 2021 Jan; 11(1):2229. PubMed ID: 33500537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cell culture system modeling the SARS-CoV-2 life cycle.
    Ju X; Zhu Y; Wang Y; Li J; Zhang J; Gong M; Ren W; Li S; Zhong J; Zhang L; Zhang QC; Zhang R; Ding Q
    PLoS Pathog; 2021 Mar; 17(3):e1009439. PubMed ID: 33711082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of the Propylamylatin
    Brown AN; Strobel G; Hanrahan KC; Sears J
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
    Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
    Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
    Xie X; Muruato AE; Zhang X; Lokugamage KG; Fontes-Garfias CR; Zou J; Liu J; Ren P; Balakrishnan M; Cihlar T; Tseng CK; Makino S; Menachery VD; Bilello JP; Shi PY
    Nat Commun; 2020 Oct; 11(1):5214. PubMed ID: 33060595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Takazawa S; Kotaki T; Nakamura S; Utsubo C; Kameoka M
    Virus Res; 2023 Sep; 334():199176. PubMed ID: 37473963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    Liu S; Chou CK; Wu WW; Luan B; Wang TT
    J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.